TC
XERS icon

TownSquare Capital’s Xeris Biopharma Holdings XERS Stock Holding History

TownSquare Capital’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,267
Closed -$25.4K – 1545
2024
Q2 		$25.4K Buy
+11,267
New +$22.7K ﹤0.01% 1284
2022
Q2 		– Sell
-10,506
Closed -$27K – 787
2022
Q1 		$27K Sell
10,506
-1,000
-9% -$2.44K ﹤0.01% 699
2021
Q4 		$34K Sell
11,506
-5,455
-32% -$11.8K ﹤0.01% 708
2021
Q3 		$42K Sell
16,961
-800
-5% -$2.32K ﹤0.01% 697
2021
Q2 		$70K Sell
17,761
-918
-5% -$3.5K ﹤0.01% 606
2021
Q1 		$84K Sell
18,679
-17,389
-48% -$93.8K ﹤0.01% 555
2020
Q4 		$177K Buy
36,068
+15,811
+78% +$79.1K 0.01% 472
2020
Q3 		$117K Sell
20,257
-4,698
-19% -$18.8K 0.01% 414
2020
Q2 		$68K Buy
+24,955
New +$86.9K ﹤0.01% 401

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

TownSquare Capital's XERS Position: Q3 2024 in Review

TownSquare Capital sold out of Xeris Biopharma Holdings (XERS) in Q3 2024, closing a stake of 11,267 shares — an estimated $25.4K sold.

TownSquare Capital first reported a position in XERS in Q2 2020 and held it in 9 quarters. The position peaked at $177K in Q4 2020. 144 funds tracked by Wall St. Rank hold XERS as of Q3 2024.

  • TownSquare Capital reported no remaining Xeris Biopharma Holdings position as of Q3 2024 after selling out during the quarter.
  • TownSquare Capital sold 11,267 Xeris Biopharma Holdings shares in Q3 2024, an estimated $25.4K.
  • TownSquare Capital first reported a position in Xeris Biopharma Holdings in Q2 2020 and held it in 9 quarters.
  • TownSquare Capital's Xeris Biopharma Holdings position peaked at $177K in Q4 2020.
  • 144 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2024.

Based on TownSquare Capital's 13F filing for Q3 2024, filed 13 Nov 2024.